Liquid chromatography coupled to tandem mass spectrometry and high resolution mass spectrometry as analytical tools to characterize multi-class cytostatic compounds.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Chromatography A

• Publication date

  2013-02-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.chroma.2012.12.031PMID 23313302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis–liquid chromatography–high-resolution mass spectrometry

  2012cited by this paper
• Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma.

  2012cited by this paper
• New developments in the trace analysis of organic water pollutants

  2012cited by this paper
• The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena.

  2012cited by this paper
• Critical evaluation of screening techniques for emerging environmental contaminants based on accurate mass measurements with time-of-flight mass spectrometry.

  2012cited by this paper
• Reaction of β-blockers and β-agonist pharmaceuticals with aqueous chlorine. Investigation of kinetics and by-products by liquid chromatography quadrupole time-of-flight mass spectrometry

  2012cited by this paper
• Accurate mass screening of pharmaceuticals and fungicides in water by U-HPLC–Exactive Orbitrap MS

  2012cited by this paper
• Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?

  2012cited by this paper
• Determination of cyclophosphamide and ifosfamide in sewage effluent by stable isotope-dilution liquid chromatography-tandem mass spectrometry.

  2011cited by this paper
• It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS.

  2011cited by this paper
• Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.

  2011cited by this paper
• High-resolution mass spectrometry method for the detection, characterization and quantitation of pharmaceuticals in water.

  2011cited by this paper
• Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra.

  2011cited by this paper
• Analysis of anticancer drugs: a review.

  2011cited by this paper
• High-throughput plasma docetaxel quantification by liquid chromatography-tandem mass spectrometry.

  2011cited by this paper
• Nontarget analysis of polar contaminants in freshwater sediments influenced by pharmaceutical industry using ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry.

  2011cited by this paper
• Occurrence, fate and determination of cytostatic pharmaceuticals in the environment

  2011cited by this paper
• Simultaneous quantification of ten cytotoxic drugs by a validated LC–ESI–MS/MS method

  2010cited by this paper
• Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma.

  2010cited by this paper
• Investigating the chlorination of acidic pharmaceuticals and by-product formation aided by an experimental design methodology.

  2010cited by this paper
• Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options

  2010cited by this paper
• High-performance liquid chromatography coupled with mass spectrometry for the quantitative analysis of vinca-alkaloids in biological matrices: a concise survey from the literature.

  2010cited by this paper
• LC–high resolution MS in environmental analysis: from target screening to the identification of unknowns

  2010cited by this paper
• Determination of drug residues in urine of dogs receiving anti-cancer chemotherapy by liquid chromatography-electrospray ionization- tandem mass spectrometry: is there an environmental or occupational risk?

  2010cited by this paper
• Rapid automated screening, identification and quantification of organic micro-contaminants and their main transformation products in wastewater and river waters using liquid chromatography-quadrupole-time-of-flight mass spectrometry with an accurate-mass database.

  2010cited by this paper
• Occurrence and fate of human pharmaceuticals in the environment.

  2010cited by this paper
• Advanced monitoring of pharmaceuticals and estrogens in the Llobregat River basin (Spain) by liquid chromatography-triple quadrupole-tandem mass spectrometry in combination with ultra performance liquid chromatography-time of flight-mass spectrometry.

  2010cited by this paper
• Screening of antibiotics in surface and wastewater samples by ultra-high-pressure liquid chromatography coupled to hybrid quadrupole time-of-flight mass spectrometry.

  2009cited by this paper
• Assays for the quantification of melphalan and its hydrolysis products in human plasma by liquid chromatography-tandem mass spectrometry.

  2009cited by this paper
• Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works.

  2009cited by this paper
• A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.

  2009cited by this paper
• Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the determination of leuprolide in human serum.

  2009cited by this paper
• Simultaneous determination of 15 steroidal oral contraceptives in water using solid-phase disk extraction followed by high performance liquid chromatography-tandem mass spectrometry.

  2009cited by this paper
• Illicit drugs in the environment

  2009cited by this paper
• Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry.

  2009cited by this paper
• Identification of transformation products of organic contaminants in natural waters by computer-aided prediction and high-resolution mass spectrometry.

  2009cited by this paper
• Accurate mass screening and identification of emerging contaminants in environmental samples by liquid chromatography-hybrid linear ion trap Orbitrap mass spectrometry.

  2009cited by this paper
• Determination of polar 1H-benzotriazoles and benzothiazoles in water by solid-phase extraction and liquid chromatography LTQ FT Orbitrap mass spectrometry

  2009cited by this paper
• Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.

  2008cited by this paper
• Quantification of Vincristine and its Major Metabolite in Human Plasma by High-Performance Liquid Chromatography/Tandem Mass Spectrometry

  2008cited by this paper
• High-performance liquid chromatography/tandem mass spectrometry method for the simultaneous determination of cytarabine and its valyl prodrug valcytarabine in rat plasma.

  2008cited by this paper
• A screening method for the detection of synthetic glucocorticosteroids in human urine by liquid chromatography–mass spectrometry based on class-characteristic fragmentation pathways

  2008cited by this paper
• Rapid non-target screening of organic pollutants in water by ultraperformance liquid chromatography coupled to time-of-light mass spectrometry

  2008cited by this paper
• Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.

  2008cited by this paper
• Validation and application of a screening method for β2‐agonists, anti‐estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry

  2007cited by this paper
• High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel.

  2007cited by this paper
• Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.

  2007cited by this paper
• A sensitive and selective liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer.

  2007cited by this paper
• Validation and application of a screening method for beta2-agonists, anti-estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry.

  2007cited by this paper
• Development of an analytical method for the determination of anthracyclines in hospital effluents.

  2006cited by this paper
• Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters.

  2006cited by this paper
• Application of liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-QqTOF-MS) in the environmental analysis.

  2006cited by this paper
• Fragmentation study of imatinib and characterization of new imatinib metabolites by liquid chromatography-triple-quadrupole and linear ion trap mass spectrometers.

  2006cited by this paper
• Trace determination of tamoxifen and 5-fluorouracil in hospital and urban wastewaters

  2006cited by this paper
• Tandem mass spectrometric analysis of cyclophosphamide, ifosfamide and their metabolites.

  2005cited by this paper
• Rapid identification of vinca alkaloids by direct-injection electrospray ionisation tandem mass spectrometry and confirmation by high-performance liquid chromatography-mass spectrometry.

  2005cited by this paper
• Development of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of flurogestone acetate in ovine plasma.

  2005cited by this paper
• Identification of the aromatase inhibitor aminoglutethimide in urine by gas chromatography/mass spectrometry.

  2002cited by this paper
• A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4.

  2001cited by this paper
• Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry.

  2001cited by this paper
• Screening and identification of unknown contaminants in water with liquid chromatography and quadrupole-orthogonal acceleration-time-of-flight tandem mass spectrometry.

  2001cited by this paper
• Rapid determination of the anti-cancer drug Melphalan (AlkeranTM) in human serum and plasma by automated solid phase extraction and liquid chromatography tandem mass spectrometry

  2000cited by this paper
• Collision-induced dissociation of corticosteroids in electrospray tandem mass spectrometry and development of a screening method by high performance liquid chromatography/tandem mass spectrometry.

  2000cited by this paper
• Pharmaceuticals and personal care products in the environment: agents of subtle change?

  1999cited by this paper
• Rapid determination of the anti-cancer drug chlorambucil (Leukeran) and its phenyl acetic acid mustard metabolite in human serum and plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry.

  1999cited by this paper
• Electrospray ionization mass spectrometry for analysis of low-molecular-weight anticancer drugs and their analogues

  1993cited by this paper

• Mass spectrometry approaches for monitoring therapeutic response in major depressive disorder.

  2025cites this paper
• Removal of the cytostatic drugs bleomycin and vincristine by white-rot fungi under various conditions, and determination of enzymes involved, degradation by-products, and toxicity.

  2024cites this paper
• Ferrocene-Containing Gallic Acid-Derivative Modified Carbon-Nanotube Electrodes for the Fast Simultaneous and Selective Determination of Cytostatics from Aqueous Solutions

  2024cites this paper
• Investigation of Iris versicolor metabolic profile and optimization of the isolation of bioactive components on a semi-operation scale

  2024cites this paper
• Pharmaceutical wastewater toxicity: An ignored threat to the public health

  2024cites this paper
• REMOÇÃO DE PREDNISONA POR ADSORÇÃO EM CARVÃO ATIVADO OBTIDO A PARTIR DO BAGAÇO DE OLIVEIRA

  2022cites this paper
• A Fluorescent Sensor for Daunorubicin Determination Using 808 nm-excited Upconversion Nanoparticles

  2021cites this paper
• Aqueous stability and degradation of psychiatric and neuroactive compounds and its biological activity in Daphnia magna.

  2021cites this paper
• Mentha arvensis mediated green synthesis of platinum doped TiO2 nanocomposite for enhanced anti-cancer and photocatalytic degradation activity: Insights from molecular docking and DFT studies

  2021cites this paper
• Characterization of neurotransmitters and related metabolites in Daphnia magna juveniles deficient in serotonin and exposed to neuroactive chemicals that affect its behavior: A targeted LC-MS/MS method.

  2020cites this paper
• Hydrogen-Bonded Films for Zero-Order Release of Leuprolide.

  2020cites this paper
• Degradation and Elimination of Anticancer Drugs by Water and Wastewater Treatment – Toxicity and Biodegradability Before and After the Treatment

  2020cites this paper
• PEGylated leuprolide with improved pharmacokinetic properties.

  2020cites this paper
• Determination of Synthetic Cathinones in Urine and Oral Fluid by Liquid Chromatography High-Resolution Mass Spectrometry and Low-Resolution Mass Spectrometry: A Method Comparison

  2020cites this paper
• Characterization of monoaminergic neurochemicals in the different brain regions of adult zebrafish.

  2020cites this paper
• BiFeO3-synthesis, characterization and its photocatalytic activity towards doxorubicin degradation from water

  2019cites this paper
• The redox mechanism investigation of non-small cell lung cancer drug: Erlotinib via theoretical and experimental techniques and its host–guest detection by β-Cyclodextrin nanoparticles modified glassy carbon electrode

  2019cites this paper
• Analysis of neurotransmitters in Daphnia magna affected by neuroactive pharmaceuticals using liquid chromatography-high resolution mass spectrometry.

  2019cites this paper
• Occurrence of anticancer drugs in the aquatic environment: a systematic review

  2019cites this paper
• Aerobic activated sludge transformation of vincristine and identification of the transformation products.

  2018cites this paper
• Investigation of the photodegradation profile of tamoxifen using spectroscopic and chromatographic analysis and multivariate curve resolution

  2018cites this paper
• Extraction protocol and liquid chromatography/tandem mass spectrometry method for determining micelle-entrapped paclitaxel at the cellular and subcellular levels: Application to a cellular uptake and distribution study.

  2018cites this paper
• Development of an analytical methodology for the analysis of priority cytostatics in water.

  2018cites this paper
• Development of a macroporous ceramic passive sampler for the monitoring of cytostatic drugs in water.

  2017cites this paper
• Mass spectrometry in the pharmacokinetic studies of anticancer natural products.

  2017cites this paper
• Biological and photochemical degradation of cytostatic drugs under laboratory conditions.

  2017cites this paper
• Anticancer drugs in Portuguese surface waters - Estimation of concentrations and identification of potentially priority drugs.

  2017cites this paper
• Determination of cytostatic drugs in Besòs River (NE Spain) and comparison with predicted environmental concentrations

  2017cites this paper
• Different sample treatments for the determination of ICM-XR in fish samples followed by LC-HRMS.

  2017cites this paper
• Anticancer drugs: Consumption trends in Spain, prediction of environmental concentrations and potential risks.

  2017cites this paper
• Liquid chromatography - mass spectrometry

  2017cites this paper
• Development and optimization of multidimensional methods based on online comprehensive microscale liquid chromatography and mass spectrometry

  2017cites this paper
• Assessment of chlorpyrifos toxic effects in zebrafish (Danio rerio) metabolism.

  2017cites this paper
• Reactivity of vinca alkaloids during water chlorination processes: Identification of their disinfection by-products by high-resolution quadrupole-Orbitrap mass spectrometry.

  2016cites this paper
• Simultaneous determination of erlotinib and tamoxifen in rat plasma using UPLC-MS/MS: Application to pharmacokinetic interaction studies.

  2016cites this paper
• Targeted metabolomics of Gammarus pulex following controlled 1 exposures to selected pharmaceuticals in water 2

  2016cites this paper
• Fabrication of an electrochemical sensor for determination of doxorubicin in human plasma and its interaction with DNA

  2016cites this paper
• Degradation of cyclophosphamide and 5-fluorouracil by UV and simulated sunlight treatments: Assessment of the enhancement of the biodegradability and toxicity.

  2016cites this paper
• Targeted metabolomics of Gammarus pulex following controlled exposures to selected pharmaceuticals in water

  2016cites this paper
• Discovery bioanalysis and in vivo pharmacology as an integrated process: a case study in oncology drug discovery.

  2016cites this paper
• Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.

  2016cites this paper
• MEDICAMENTOS ANTINEOPLÁSICOS NO MEIO AMBIENTE: A CONTRIBUIÇÃO DE UM HOSPITAL UNIVERSITÁRIO DE ALTA COMPLEXIDADE

  2016cites this paper
• Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain).

  2015cites this paper
• Electrochemical Biosensors Based on Native DNA and Nanosized Mediator for the Detection of Anthracycline Preparations

  2015cites this paper
• Entwicklung und Anwendung von UHPLC-MS Verfahren für organische Spurenstoffe zur Bewertung der Sicherheit der Rohwasserressourcen der Wasserwerke der Stadt Berlin

  2015influential citation
• Identification of Novel Impurities in Minomustine by Liquid Chromatography–Mass Spectrometry

  2015cites this paper
• Separation, Identification, and Characterization of Degradation Products of Erlotinib Hydrochloride Under ICH-Recommended Stress Conditions by LC, LC-MS/TOF

  2015cites this paper
• DETERMINATION OF CAPECITABINE-AN ANTICANCER DRUG IN DRIED BLOOD SPOT BY LC-ESI-MS/MS Original Article

  2015cites this paper
• Rapid label-free determination of ketamine in whole blood using secondary ion mass spectrometry.

  2015cites this paper
• Multi-residue analysis of pharmaceuticals in wastewater by liquid chromatography-magnetic sector mass spectrometry: method quality assessment and application in a Belgian case study.

  2015cites this paper
• Large Volume Injection of Aqueous Samples in Nano Liquid Chromatography Using Serially Coupled Columns

  2014cites this paper
• Screening und Quantifizierung organischer Spurenstoffe mittels UPLC-HRMS

  2014influential citation
• Occurrence and Ecotoxicological Risk Assessment of 14 Cytostatic Drugs in Wastewater

  2014cites this paper
• Comparison of triple quadrupole mass spectrometry and Orbitrap high-resolution mass spectrometry in ultrahigh performance liquid chromatography for the determination of veterinary drugs in sewage: benefits and drawbacks.

  2014cites this paper
• Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry

  2014cites this paper
• Multianalyte determination of 24 cytostatics and metabolites by liquid chromatography-electrospray-tandem mass spectrometry and study of their stability and optimum storage conditions in aqueous solution.

  2013cites this paper
• The benefits of high resolution mass spectrometry in environmental analysis.

  2013cites this paper